Development of Monoclonal Antibodies against CMP-N-Acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 (ST3Gal-I) Recombinant Protein Expressed in E. coli

Aberrant glycosylation is one of the major hallmarks of cancer with altered gene expression signatures of sialyltransferases. ST3Gal-I, a sialyltransferase, is known to play a crucial role in sialylation of T antigen in bladder cancer and it has reported elevated expression in breast carcinogenesis...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biochem Res Int
Autors principals: Gupta, Anuj Kumar, Kaur, Parvinder, Patil, Harshada, Kadam, Pallavi, Bhanushali, Paresh B., Chugh, Manoj
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2015
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4689901/
https://ncbi.nlm.nih.gov/pubmed/26783462
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/767204
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars